129P Integration of gene expression and tumor-infiltrating lymphocytes (TILs) to predict pCR after neoadjuvant chemotherapy and nivolumab for patients with luminal B-like breast cancer in the phase II GIADA trial

Subjects

Subjects :

Chemotherapy
business.industry
Tumor-infiltrating lymphocytes
medicine.medical_treatment
Hematology
Luminal b
medicine.disease
Breast cancer
Oncology
Gene expression
Cancer research
Medicine
Nivolumab
business

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........f2813082a95ec939b5ec516b3d29a809

Full Text :

https://doi.org/10.1016/j.annonc.2021.08.410